Jayaramu et al
IAJPS 2015, 2 (10), 1393-1398
CODEN (USA): IAJPBB
ISSN 2349-7750
ISSN: 2349-7750
INDO AMERICAN JOURNAL OF
PHARMACEUTICAL SCIENCES
Available online at: http://www.iajps.com
Research Article
SYNTHESIS AND INVITRO BIOLOGICAL ACTIVITIES OF
SOME NOVEL ACRYLOYL CHROMENE-4-ONE DERIVATIVES.
Sheth Chintan*, Prakasha Kaggere Jayaramu*, Rohini R Maralihallia
*
Department of Pharmaceutical Chemistry, Al-Ameen College of Pharmacy, Hosur Road, Bengaluru
560027, Karnataka, India.
a
Professor, Department of Pharmaceutical Chemistry, Al-Ameen College of Pharmacy, Hosur Road
Bengaluru 560027, Karnataka, India.
Abstract:
Some new acryloyl chromene-4-one derivatives were synthesized by Claisen-Schmidt condensation of 2-hydroxy
acetophenone and benzaldehyde to form Chalcones which on further oxidative cyclization gives Flavone. Further on
acetylation of Flavone, compound obtained was reacted with different substituted benzaldehyde to give acryloyl
chromone-4-one derivatives. CN (1–10). The Characterization of newly synthesized compounds done on the
basis of UV, IR, 1HNMR, 13CNMR, Mass spectral data. All the synthesized compounds were evaluated for their
anti-inflammatory and antitubercular activity.
Keywords: chromene-4-one derivatives, Flavones, Spectral data, Anti-inflammatory activity, Antitubercular
activity.
Corresponding Author:
Prakasha Kaggere Jayaramu,
Department of Pharmaceutical Chemistry,
Al-Ameen College of Pharmacy, Hosur Road,
Bengaluru 560027,
Karnataka, India
Email ID: prakashakj@gmail.com
QR code
Please cite this article in press as Jayaramu et al , Synthesis and In vitro Biological Activities of Some Novel
Acryloyl Chromene-4-One Derivatives , Indo Am. J. Pharm. Sci, 2015;2(10).
www.iajps.com
Page 1393
IAJPS 2015, 2 (10), 1393-1398
INTRODUCTION
Inflammation is a part of the complex biological
response of the vascular tissues due to harmful
stimuli. The signs of acute inflammation are pain,
heat, redness and loss of functions. Acute
inflammation is the initial response of the body to the
harmful stimuli and is achieved by the increased
movement of plasma and leukocytes from the blood
into the injured tissues. Non-steroidal antiinflammatory drugs (NSAIDs) are commonly
prescribed for the treatment of acute and chronic
inflammation, pain and fever. Most of the NSAIDs
that are available in the market are known to inhibit
isoforms, a constitutive form COX-1 and an
inducible form, COX-2 to offer therapeutic effect.
However, long term clinical usage NSAIDs is
associated with significant side effects of gastric
lesions, bleeding and nephrotoxicity [1]. Therefore,
the discovery of new safer anti-inflammatory drugs
represents a challenging goal for such a research area.
Tuberculosis (TB) is one of the oldest and most
pervasive diseases in history. According to alarming
data from the World Health Organization (WHO),
TB has spread to every corner of the globe. As much
as one third of the world’s population is currently
infected and more than 5000 people die from TB
every day. It is estimated that between 2002 and
2020, approximately 1000 million people will be
newly infected, over 150 million people develop
diseases and 36 million will die of TB if proper
control measures are not established. The Direct
Observed Treatment Short Course (DOTS) strategy
constitutes the corner stone of the current protocol for
control of TB. However, the three key drugs,
isoniazide, pyrazinamide and rifampicin, used in the
regimen are potentially hepatotoxic and may lead to
drug-associated hepatitis.
The flavones (2-phenylchromones) are naturally
occurring heterocyclic compound belonging to the
flavanoid group and are widely distributed in
vascular plants [2]. Their attraction as synthetic
targets is due to wide range of biological activities
exhibited by them. Their presence being a century
old [3], isolation of new flavones [4] and new
methods of synthesis continue till to date. The
flavones derivatives are investigated and reported for
leishmanicidal
activity,
oviposter
stimulant
www.iajps.com
Jayaramu et al
ISSN 2349-7750
phytoalexins, anti-HIV, vasodilator, antiviral, antioxidants,
bactericidal,
anti-inflammatory,
antimutagenics, antiallergic and anticancer [5].
Moreover, it is known that some flavones have a
repelling property against some phytophagous
insects[6-7].
MATERIALS AND METHODS
All the melting points were determined in a
Thermonik melting point apparatus and are
uncorrected. The IR spectra of the synthesized
compounds was recorded on a Fourier Transform IR
spectrometer (model Shimadzu 8700) in the range of
400-4000 cm-1 using KBr pellets and 1H NMR
spectra was recorded on Amx - 400 MHz NMR
spectrometer using DMSO and the chemical shifts (δ)
reported are in parts per million downfield using
tetramethylsilane (TMS) as internal reference. 13CNMR spectra was recorded on Amx - 400 MHz NMR
spectrometer using DMSO and the chemical shifts (δ)
reported are in parts per million downfield using
tetramethylsilane (TMS) as an internal reference.
Mass
spectrum
was
recorded
on
Mass
spectrophotometer (model Shimadzu) by LC-MS
2010A. The purity of the compounds was checked by
thin-layer chromatography on silica gel G plates of
0.5 mm thickness as stationary phase and
combination of n-hexane: ethyl acetate in different
ratios as mobile phase. The UV spectra of the
synthesized compounds were recorded on UV–
Visible spectrophotometer (model Shimadzu 1601)
using methanol and the values of absorption maxima
(λmax) were reported in nm.
RESULTS AND DISSCUSSION
Antitubercular Activity [8-9]:
All the synthesized compounds were screened for invitro antitubercular activity by Microplate Alamar
Blue Assay(MABA) method using Indomethacin as
standard. Compounds of CN series were tested for
antitubercular activity at concentration of 100 µg/ml
to 0.8 µg/ml against the M. Tuberculosis ATTS
27294. All the derivatives exhibited antitubercular
activity at 100 µg/ml. The results are given in the
following table 1.
Page 1394
Jayaramu et al
IAJPS 2015, 2 (10), 1393-1398
ISSN 2349-7750
Table 1: Antitubercular Activity
Sl. No
Compounds
100µg/ml
50µg/ml
25µg/ml
1
CN 1
S
S
S
CN 2
CN 3
CN 4
CN 5
CN 6
CN 7
CN 8
CN 9
CN 10
Isoniazide
S
S
S
S
S
S
S
S
S
S
S
S
R
S
S
S
R
S
R
S
S
S
R
R
R
R
R
R
R
S
2
3
4
5
6
7
8
9
10
Standard
S-Sensitive
R-Resistant
Anti-inflammatory Activity [10]:
The anti-inflammatory activity of the synthesized
compounds tested at 100 and 200 µg/ml for antiinflammatory activityby Bovine serum albumin
(BSA) method and Indomethacin was used as
positive control. Moderate activity was exhibited,
dose dependent activity was observed for CN 1, CN
6, CN 8 and CN 9 respectively. The results are
demonstrated in table 2.
Table 2: Anti-inflammatory activity
Compound
Code
CN 1
CN 2
CN 3
CN 4
CN 5
CN 6
CN 7
CN 8
CN 9
CN 10
Indomethacin
% Inhibition
100 µg/ml
200µg/ml
38
52
60
50
44
43
33
27
65
52
49
51
58
56
32
59
48
51
34
44
86
88
Synthesis of 1-(2-Hydroxy phenyl)-3-phenylpropenone. (3)
Equimolar
quantity
(0.01
mol)
of
2hydroxyacetophenone (1) and benzaldehyde (2) (0.01
mol) were dissolved in ethanol with aqueous KOH
www.iajps.com
12.5µg/ml
6.25µg/ml
3.12µg/ml
1.6µg/ml
0.8µg/ml
S
S
R
R
R
R
S
R
R
R
R
R
R
R
S
R
R
R
R
R
R
R
R
R
S
R
R
R
R
R
R
R
R
R
S
R
R
R
R
R
R
R
R
R
S
R
R
R
R
R
R
R
R
R
S
and stirred for 6 hours by magnetic stirrer. Kept
overnight. The reaction mixture was diluted with
water, acidified with 10 % HCl to give chalcone (3).
The obtained compound was recrystalized from
ethanol.
Synthesis of 2-phenyl-chromene-4-one. (4)
Chalcones (3) (0.01 mol) was suspended in DMSO
and crystal of Iodine was added to it and refluxed for
2.5 hrs. Reaction mixture was diluted with water, the
obtained solid product is washed with 20% sodium
thiosulphate and crude flavones (4) obtained was
recrystalized from ethanol.
Synthesis of 2-(4-acetyl phenyl)-chromene-4-one.
(5)
Equimolar quantity of Flavones (4) and acetic
anhydride were mixed in round bottom flask with
ethanol as a solvent. Anhydrous aluminium chloride
was added as a catalyst in the reaction and refluxed
for 3.5 hrs. The reaction mixture was cooled and
poured in crushed ice. The obtained acetylated
product (5) was filtered and recrystalized from
ethanol.
Synthesis of 2-[4-(3-acryloyl)-phenyl]-chromene-4one. CN (1 – 10)
Equimolar quantity of 2-(4-acetyl phenyl)-chromene4-one (5) and different substituted benzaldehyde
were dissolved in ethanol and aq. KOH and kept for
stirring for 6 hrs and left overnight. The reaction
mixture was diluted with water, and neutralized with
10 % HCl to obtain acryloyl phenyl chromene-4-one
derivatives. The compounds obtained CN (1 – 10)
were recrystalized from ethanol.
Page 1395
Jayaramu et al
IAJPS 2015, 2 (10), 1393-1398
ISSN 2349-7750
Scheme of Synthesis:
O
O
C
CH3
CHO
C
C
H
C
H
Ethanol
+
KOH
OH
OH
1
3
2
Chalcone
DMSO/I2
COCH3
O
O
(CH3CO)2O
Alcl3
O
O
CHO
4
Flavone
5
X
O
C
X
C
H
C
H
O
O
6
CN (1-10)
www.iajps.com
X=3,4,5 -OCH3
p -NO2
m -Cl
p -CH3
m -No2
2,4 -OCH3
m -CH3
3,4 -OCH3
2 -OH
C4H4O
Page 1396
IAJPS 2015, 2 (10), 1393-1398
2-{4-[3-(3, 4, 5-trimethoxy-phenyl)-acryloyl]phenyl}-chromene-4-one. (CN 1): Yield 48%;
m.p.148°C; λmax=304nm; IR(KBr)cm-11676 (C=O),
1598 (C=C), 3064 (C-H), 1525 (C=C), 1266 (C-O
str). 1HNMR(DMSO) δ 8.1 (d, 1H),δ 7.8(m, 6H), δ
7.6(d, 1H, 1H), δ 7.5(s, 1H,), δ 3.9(t, 9H, OCH3).13CNMR (DMSO) δ 180, 187 (C=O), δ 179 (CH), δ
152 (CH), δ 149 (C=O) δ 128, 127, 126, 124, 106
(aryl carbons).
2-{4-[3-(4-nitro-phenyl)-acryloyl]-phenyl}chromene-4-one. (CN 2): Yield 56%; m.p.145°C;
λmax=319nm;
IR (KBr) cm-1 1691 (C=O), 1606
(C=C), 3066 (C-H), 1519 (C=C), 1292 (C-O str).
1
HNMR (DMSO) δ 8.1 (d, 1H), δ 7.7 (m, 8H) δ 7.6
(d, 1H), δ 7.1 (s, 1H). 13CNMR (DMSO) δ 192, 172,
149, 131, 128, 124, 123, δ 178 (C=O), δ 150 (C), δ
129 (C).
2-{4-[3-(3-chloro-phenyl)-acryloyl]-phenyl}chromene-4-one. (CN 3): Yield 54%; m.p.151°C;
λmax=317nm; IR (KBr) cm-1 1660 (C=O), 1593
(C=C), 3089 (C-H), 1525 (C=C), 1250 (C-Ostr).
1
HNMR (DMSO) δ 8.0(d, 1H), δ 7.6 (d, 1H), δ
7.51(s, 1H), δ 7.4 (m, 8H, Ar).13CNMR (DMSO) δ
180 (C=O), δ 166, 134 (C=Cδ 187, 132, 129, 127,
126, 124, 187 (aryl carbon)
2-[4-(3-p-tolyl-acryloyl)-phenyl]-chromene-4-one.
(CN 4): Yield 62%; m.p.145°C; λmax=307nm; IR
(KBr) cm-1 1677 (C=O), 1607 (C=C), 3062 (C–H),
1535 (C=C), 1262 (C–O str). 1HNMR (DMSO) δ
7.95(d, 1H), δ 7.7(s, 1H), δ 7.5 (d, 1H), δ7.4 (m,
8H),δ 2.5(s, 3H, CH3).13CNMR (DMSO) δ 188 (C), δ
187, 179, 149, 131, 128, 124, 123 (aryl carbon)δ
152,129 (C=C).
2-{4-[3-(3-nitro-phenyl)-acryloyl]-phenyl}chromene-4-one. (CN 5): Yield 58%; m.p.146°C,
λmax=310nm; IR (KBr) cm-1 1689 (C=O), 1604
(C=C), 3070 (C-H), 1521 (C=C), 1294 (C-O
str).1HNMR (DMSO) δ 8.5(d, 1H), δ 7.5 (s, 1H), δ
7.2 (m, 8H, Ar), δ 7.04 (d, 1H).13CNMR (DMSO) δ
191, 155 (C=C), δ 148, 141, 140, 131, 128, 128, 127,
188, 177 (aryl carbon)
2-{4-[3-(2, 4-dimethoxy-phenyl)-acryloyl]-phenyl}chromene-4-one.
(CN 6): Yield 49%;
m.p.150°C;λmax=311nm; IR (KBr) cm-11645 (C=O),
1591 (C=C), 3004 (C–H), 1519 (C=C), 1213 (C-O
str).
2-[4-(3-m-tolyl-acrloyl)-phenyl]-chromene-4-one
(CN 7): Yield 60%; m.p.142°C, λmax=310nm; IR
(KBr) cm-1 1663 (C=O), 1638 (C=C), 3032 (C–H),
1561 (C=C), 1260 (C-O).
2-{4-[3-(3, 4-dimethoxy-phenyl)-acryloyl]-phenyl}chromene-4-one. (CN 8): Yield 54%; m.p.155°C;
www.iajps.com
Jayaramu et al
ISSN 2349-7750
λmax=319nm; IR (KBr) cm-1 1686 (C=O), 1609
(C=C), 3033 (C–H), 1562 (C=C), 1249 (C–O str).
2-{4-[3-(2-hydroxy-phenyl)-acryloyl]-phenyl}chromene-4-one.
(CN
9):
Yield
60%;
m.p.138°C;λmax=311nm; IR (KBr) cm-1 1663 (C=O),
1638 (C=C), 3032 (C–H), 1561 (C=C), 1280 (C–O
str).
2-{4-[3-(4-furan-2-yl-phenyl)-acryloyl]-phenyl}chromene-4-one.
(CN
10):
Yield
55%;
m.p.142°C;.λmax=320nm;IR (KBr) cm-11684 (C=O),
1609 (C=C), 3031 (C-H), 1512 (C=C), 1251 (COstr).
Antitubercular Activity
The antitubercular activity of compounds was
assessed against M. Tuberculosis using Microplate
Alamar Blue Assay (MABA). Briefly, 200 µl of
sterile 96 wells plate was taken to minimize
evaporation of medium in the test wells during
incubation. The 96 wells plate received 100 µ l of the
Middlebrook 7H9 broth and serial dilution of
compounds were made directly on plate. The final
drug concentrations tested were 100 to 0.8 µg /ml.
Plates were covered and sealed with parafilm and
incubated at 37oC for five days. After this time, 25µ l
of freshly prepared 1:1 mixture of Alamar Blue
reagent and 10 % tween 80 was added to the plate
and incubated for 24 hrs. A blue color in the well was
interpreted as no bacterial growth, and pink color was
scored as growth.
Anti-Inflammatory Activity
A solution of 0.2 % w/v of Bovine serum albumin
(BSA) was prepared in Tris buffer saline and pH was
adjusted to 6.8 using glacial acetic acid. Stock
solutions of 1000 µg /ml of all test samples were
prepared by using methanol as a solvent. From the
stock solutions two different concentrations of 100
µg /ml and 200 µg /ml were prepared by using
methanol as a solvent. 100 µg /ml of each test
sample was taken to which 5ml of 0.2 % BSA was
added. The control consists of 5ml 0.2 % w/v BSA
solution with 0.1ml methanol. The 0.1ml standard
contains 100 µg /ml of Indomethacin in methanol
with 5ml 0.2 % w/v BSA solution. The volumetric
flasks were heated at 72°C for 5 minutes and then
cooled for 10 minutes. The absorbance of these
solutions was determined by using spectrophotometer
at a wavelength of 660 nm. The % denaturation of the
protein (% inhibition) was determined by using
formula as given.
Absorbance of Control – Absorbance of Test
% inhibition = ------------------------------------------------X 100
Absorbance of Control
Page 1397
IAJPS 2015, 2 (10), 1393-1398
CONCLUSION
In the conclusion novel acryloyl phenyl chromene-4one derivatives were synthesized and proved by
spectral data. All the synthesized compounds were
screened for In-vitro anti-inflammatory activity by
Bovine Serum Albumin method. Compounds CN - 2,
5, 7 were active at very low dose of 100 µg/ml and
CN - 1, 2, 5, 6, 7, 8, 9 have showed dose dependant
activity, exhibiting moderate activity of 50-60 %
inhibition of inflammation. This activity would be
attributed due to presence of trimethoxy, dimethoxy
and hydroxyl group of the substituted chalcone.
The new acryloyl phenyl chromone-4-one derivatives
have shown promising results against M.
Tuberculosis ATTS 27294, indicating the flavones
moiety may be contributing for activity. The efficacy
of activity was not altered by cyclization of chalcone
to pyrimidine nucleus for CN 3, CN 5 and CN 7,
demonstrates chalcone moiety may be responsible for
their positive results. Sensitivity towards M.
Tuberculosis for compound CN 1 can purely be
attributed to for the trimethoxy group of chalcone
moiety along with flavone moiety.
ACKNOWLEDGMENT
The authors wish to thank B G Shivananda former
principal, Al-Ameen college of Pharmacy, Bengaluru
for encouraging and providing facility to carry out
the research work. Mr Manish, Punjab University,
Chandigarh for providing the NMR spectra and Dr.
Kishore G Bhat, Professor Department of
Biotechnology, MM’S Halagekar Institute of Dental
www.iajps.com
Jayaramu et al
ISSN 2349-7750
Sciences and Research center, Belgaum for screening
the synthesized compounds for antitubercular
activity.
REFERENCES
1.Pandurangan N, Bose C, Banergi A. Synthesis and
Antioxygenic activities of seabuckthorn flavones-3ols and analogs. Bioorg Med ChemLett, 2011;
21:5328-5330.
2.Harborne BJ, Williams CA, Advances in flavonoids
since 1192. Nat Prod Rep, 2001; 18:310-315.
3.Whitting DA. Chemistry of flavonoids. Nat Prod
Rep, 2001; 18:583-591.
4.Rao YK, Rao CV, Kishore PH, Gunasekar D.
Flavonol as a natural product. J Nat Prod, 2001;
64:368-373.
5.Helavi YB, Solabannavar SB, Salunkhe RS, Mane
RB. Chemistry and synthesis of new flavone
derivatives. J Chem Res Synop, 2003; 279-289.
6.Seijas JA, Vazues TMP, Carballido RR, Synthesis
and antioxidant activity of some novel flavone
derivatives. J Org Chem, 2005; 70:2855-2867.
7.Morimoto M, Tanimoto K, Nakano S, Ozaki T,
Nakano A, Komai K. Chemistry, synthesis and
biological evaluation of some novel flavonoid
derivatives. J Agric Food Chem, 2003; 51:389-398.
8.K Elumalai, MA Ali, M Elumalai, K Eluri, S.
Srinivasan, J Acute Disease., 2011, 321.
9AR Trivedi, DK K. Dodiya, NR Ravat, VH Shah.
ARKIVOC., 2008, Xi, 141.
10.CMBhalgat, MI Ali, B Ramesh, G Ramu, Ara J
Chem., 2011, 8.
Page 1398